EP1918305 - New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 30.10.2009 Database last updated on 19.10.2024 | Most recent event Tooltip | 30.10.2009 | Application deemed to be withdrawn | published on 02.12.2009 [2009/49] | Applicant(s) | For all designated states Biogen Idec Inc. 14 Cambridge Center Cambridge, MA 02142 / US | [N/P] |
Former [2008/19] | For all designated states Biogen Idec Inc. 14 Cambridge Center Cambridge MA 02142 / US | Inventor(s) | 01 /
Rastetter, William 17153 El Mirador Rancho Santa Fe, CA 92067 / US | 02 /
White, Christine P.O. Box 9242 Rancho Santa Fe, CA 92067 / US | [2008/30] |
Former [2008/19] | 01 /
Rastetter, William 16067 Puerta del Sol Rancho Santa Fe, CA 92067 / US | ||
02 /
White, Christine P.O. Box 9242 Rancho Santa Fe, CA 92067 / US | Representative(s) | Adams, Harvey Vaughan John Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG / GB | [N/P] |
Former [2008/19] | Adams, Harvey Vaughan John Mathys & Squire 120 Holborn London EC1N 2SQ / GB | Application number, filing date | 08101697.4 | 31.07.2000 | [2008/19] | Priority number, date | US19990148288P | 11.08.1999 Original published format: US 148288 P | US20000625856 | 26.07.2000 Original published format: US 625856 | [2008/19] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1918305 | Date: | 07.05.2008 | Language: | EN | [2008/19] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 02.04.2008 | Classification | IPC: | C07K16/28, A61K39/395 | [2008/19] | CPC: |
C07K16/2896 (EP);
A61P35/00 (EP);
A61K2039/505 (EP)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2008/19] | Title | German: | Neue klinische Parameter zur Bestimmung der hämatologischen Toxizität vor einer Strahlenimmuntherapie | [2008/19] | English: | New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy | [2008/19] | French: | Nouveaux paramètres cliniques pour déterminer la toxicité hématologique avant une radioimmunothérapie | [2008/19] | Examination procedure | 07.11.2008 | Examination requested [2008/51] | 04.12.2008 | Despatch of a communication from the examining division (Time limit: M06) | 16.06.2009 | Application deemed to be withdrawn, date of legal effect [2009/49] | 17.07.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2009/49] | Parent application(s) Tooltip | EP00959150.4 / EP1207904 | Fees paid | Renewal fee | 15.02.2008 | Renewal fee patent year 03 | 15.02.2008 | Renewal fee patent year 04 | 15.02.2008 | Renewal fee patent year 05 | 15.02.2008 | Renewal fee patent year 06 | 15.02.2008 | Renewal fee patent year 07 | 15.02.2008 | Renewal fee patent year 08 | 25.07.2008 | Renewal fee patent year 09 | Penalty fee | Additional fee for renewal fee | 31.07.2009 | 10   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO9411026 (IDEC PHARMA CORP [US]); | by applicant | US4636380 | US4831175 | US5099069 | WO9207466 | US5124471 | US5246692 | US5286850 | US5460785 | US5843398 | US5843439 | US6399061 | US2002102208 | US6682734 |